Synthesis and Anti-inflammatory Effect of Chalcones
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The process of degranulation of mast cells and neutrophils contributes to inflammatory disorders. Activation of microglial cells and macrophages is believed to be involved in inflammatory, infectious and degenerative diseases of the CNS. Combining the potent inhibition of chemical mediators released by the degranulation of mast cells or neutrophils and from the activated microglial cells or macrophages, would lead to a promising antiinflammatory agent for the treatment of peripheral and central inflammation. A series of chalcone derivatives have been reported to have potent anti-inflammatory activity. In an effort to continually develop potent anti-inflammatory agents, novel series of chalcones, 2′-hydroxy- and 2′,5′-dihydroxychalcones were synthesized and their inhibitory effects on the activation of mast cells, neutrophils, microglial cells and macrophages were evaluated in-vitro. The chalcones were prepared by Claisen-Schmidt condensation of appropriate acetophenones with an appropriate aromatic aldehyde. The alkoxychalcones were prepared with appropriate hydroxychalcones and alkyl iodide and the dihydroxychalcones were prepared by hydrogenation of an appropriate chalcone with Pd/C. Almost all of the hydroxychalcones exhibited potent inhibitory effects on the release of β-glucuronidase and lysozyme from rat neutrophils stimulated with formyl-Met-Leu-Phe/cytochalasin B (fMLP/CB). Of the hydroxychalcones, compound 1 was the most potent inhibitor of the release of β-glucuronidase (IC50=1.6 ± 0.2 μM) and lysozyme (IC50=1.4 ± 0.2 μM) from rat neutrophils stimulated with fMLP/CB. Almost all of the 2′,5′-dialkoxychalcones exhibited potent inhibitory effects on nitric oxide (NO) formation from murine microglial cell lines N9 stimulated with lipopolysaccharide (LPS). Of these, compound 11 showed the greatest effect (IC50=0.7 ± 0.06 μM). The present results demonstrated that most of the chalcone derivatives have an anti-inflammatory effect. The inhibitory effects of dialkoxychalcones, 10–12 on inflammation are probably not due to the inhibition of mast cells and neutrophil degranulation, but are mediated through the suppression of NO formation from N9 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314 · cited 2×
“Hence, inhibition of NO released from microglial cells or macrophages is a rational therapeutic approach to treat a variety of in¯ammatory and neuronal conditions observed in ageing and Alzheimer's disease (Meda et al 1995).”
Background
Cited by
A review of anti-infective and anti-inflammatory chalcones
Nowakowska, Z. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.09.019 · Cited by 1,084
Hydroxyapatite: A review of syntheses, structure and applications in heterogeneous catalysis
Fihri, A., Len, C., Varma, R. S., & Solhy, A. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.06.009 · Cited by 519
Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents
Won, S.-J., Liu, C.-T., Tsao, L.-T., Weng, J.-R., Ko, H.-H., Wang, J.-P., & Lin, C.-N. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.09.006 · Cited by 287
Self-citationChalcones: Synthetic Chemistry Follows Where Nature Leads
Jasim, H. A., Nahar, L., Jasim, M. A., Moore, S. A., Ritchie, K. J., & Sarker, S. D. (2021) · Biomolecules · doi:10.3390/biom11081203 · Cited by 167
Metadata
- Authors
- Hsieh, H.-K., Tsao, L.-T., Wang, J.-P., & Lin, C.-N.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-02-01
- Volume
- 52
- Issue
- 2
- Pages
- 163-171
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2166782978
- Cited by
- 213
- References
- 2
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.